Xilio Therapeutics, Inc. ($XLO)
Brennan Kevin M. โ SVP, FINANCE AND ACCOUNTING
Shares
95,221
Price
$0.00
Total Value
$0.00
Nearby Earnings
No earnings within 2 weeks of this transaction.
Transaction Details
| Insider | Brennan Kevin M. |
|---|---|
| Title | SVP, FINANCE AND ACCOUNTING |
| Transaction Date | Dec 31, 2025 |
| Expiration Date | Oct 7, 2035 |
| Transaction Code | A Grant/Award |
| Acquired/Disposed | Acquired |
| Security | Stock Option (right to buy) |
| Derivative | Yes |
| Direct/Indirect | Direct |
| Filing Date | Jan 5, 2026 |
| Shares Purchased | 95,221 |
| Price per Share | $0.00 |
| Total Value | $0.00 |
| Shares Owned After | 95,221 |
| Derivative | Derivative |
| Accession Number | 0001193125-26-002518 |
| Document | View SEC Filing |